Add to ORKGEvidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athlete
In the Italian screening protocol, the ECG is evaluated in light of the athlete's gender, age, race,...
To determine the feasibility of detecting cardiovascular disease in a large group of young competiti...
he 1996 American Heart Association consensus panel recommendations stated that pre-participation car...
AIMS: Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden death in young athletes, and su...
pre-participation screening programme for identification of hypertrophic cardiomyopathy in competiti...
The 1996 American Heart Association consensus panel recommendations stated that pre-participation ca...
The 1996 American Heart Association consensus panel recommendations stated that pre-participation ca...
The 1996 American Heart Association consensus panel recommendations stated that pre-participation ca...
Aims: This study aimed to report the long-term findings of the Italian programme of cardiovascular p...
The 1996 American Heart Association consensus panel recommendations stated that pre-participation c...
associated with competitive sports in the setting of known cardiovascular disease is a controllable ...
In 1982 a nationwide program of pre-participation screening including 12-lead electrocardiography (E...
In 1982 a nationwide program of pre-participation screening including 12-lead electrocardiography (E...
ObjectivesThis study sought to determine the prevalence of hypertrophic cardiomyopathy (HCM) in elit...
Both the American Heart Association and the European Society of Cardiology consensus panel recommend...
In the Italian screening protocol, the ECG is evaluated in light of the athlete's gender, age, race,...
To determine the feasibility of detecting cardiovascular disease in a large group of young competiti...
he 1996 American Heart Association consensus panel recommendations stated that pre-participation car...
AIMS: Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden death in young athletes, and su...
pre-participation screening programme for identification of hypertrophic cardiomyopathy in competiti...
The 1996 American Heart Association consensus panel recommendations stated that pre-participation ca...
The 1996 American Heart Association consensus panel recommendations stated that pre-participation ca...
The 1996 American Heart Association consensus panel recommendations stated that pre-participation ca...
Aims: This study aimed to report the long-term findings of the Italian programme of cardiovascular p...
The 1996 American Heart Association consensus panel recommendations stated that pre-participation c...
associated with competitive sports in the setting of known cardiovascular disease is a controllable ...
In 1982 a nationwide program of pre-participation screening including 12-lead electrocardiography (E...
In 1982 a nationwide program of pre-participation screening including 12-lead electrocardiography (E...
ObjectivesThis study sought to determine the prevalence of hypertrophic cardiomyopathy (HCM) in elit...
Both the American Heart Association and the European Society of Cardiology consensus panel recommend...
In the Italian screening protocol, the ECG is evaluated in light of the athlete's gender, age, race,...
To determine the feasibility of detecting cardiovascular disease in a large group of young competiti...
he 1996 American Heart Association consensus panel recommendations stated that pre-participation car...